Home/Stocks/Financials

Chesnara PLC

CSN.L·Financials·Market Cap £746m
Rank #88 of 280
Quantitative Model · 280 Stocks Analysed
£3.22
+6.98% YTD
52W: £2.65 - £3.78

Factor Analysis Summary

Editorial assessment generated from Chesnara PLC's live factor scores and sector positioning.

Based on Strategyland's proprietary 7-factor analysis, Chesnara PLC (CSN.L) currently holds an overall rank of #88 out of 280 FTSE 100 constituents, reflecting its weighted composite score across liquidity, valuation, profitability, solvency, asset efficiency, market trading, and technical dimensions.

Key strengths include liquidity, where it demonstrates exceptional market liquidity with deep trading volumes that support efficient entry and exit; profitability (ROE -2.8%, net margin 0.2%), where it demonstrates healthy profit margins and returns that exceed the median FTSE 100 company; and technical (RSI 10.6), where it demonstrates generally favourable technical indicators with price holding above key moving averages.

Areas requiring attention include solvency (debt/equity 0.4), where higher debt levels or weaker coverage ratios raise solvency concerns, as well as asset efficiency, where poor capital efficiency suggests assets may be underutilised or overvalued on the balance sheet.

Within the Financials sector, Chesnara PLC sits at composite rank #88, trailing the Financials peer average (rank 8). It ranks behind all 6 tracked Financials peers in our model.

At composite rank #88 (top 69% of the FTSE 100 universe), Chesnara PLC presents a mixed profile: liquidity provides the clearest positive signal, while solvency remains the primary constraint on its overall score.

Strongest Factors

  • Liquidity — Rank 35/280 (top quartile)
  • Profitability — Rank 89/280 (above average)
  • Technical — Rank 112/280 (above average)

Weakest Factors

  • Solvency — Rank 232/280 (below average)
  • Asset Efficiency — Rank 227/280 (below average)

Score Analysis

Chesnara PLC is ranked #88 out of 280 UK stocks. Lower factor scores indicate better performance in that category.

Factor Breakdown

141/280
Average Score
Liquidity
Excellent35/280
Valuation
Fair168/280
Profitability
Good89/280
Solvency
Weak232/280
Asset Efficiency
Weak227/280
Mkt Trading
Fair125/280
Technical
Good112/280

1. Liquidity

Score: 35/280

How liquid is CSN and can it meet its short-term obligations?

0/6
liquidity criteria met
–
Quick RatioN/A
Range: N/A
–
Current RatioN/A
Range: N/A
–
TTM Operating Cash FlowN/A
Range: N/A
–
Liquidity Coverage RatioN/A
Range: 100-150
✗
Intangible Asset Ratio0.01x
Range: 10 - 30Rank 154/280
–
Cash-to-Debt Ratio0.71x
Range: N/ARank 69/280

Key Liquidity Metrics

Quick Ratio
N/A
Sector: N/A
Current Ratio
N/A
Sector: N/A

Overall Liquidity Rank

Rank within universe#35/280
Best (1)Worst (280)

2. Valuation

Score: 168/280

Is CSN undervalued compared to its peers and fair value metrics?

4/7
valuation criteria met
✓
FY27e P/E11.9x
Range: 8x - 18xRank 106/280
✓
FY26e P/E13.8x
Range: 8x - 18xRank 122/280
✓
FY27e Net Div Yld (%)7.48%
Range: 3.0 - 8.0Rank 21/280
✗
Div Payout Ratio4740.00%
Range: 30 - 55Rank 25/280
–
Current EV/EBITDA19.3x
Range: N/ARank 245/280
✗
Current P/TBV2.12x
Range: 0.8x - 2.0xRank 129/280
✓
Current P/B1.67x
Range: 0.8x - 2.0xRank 146/280

Key Valuation Metrics

TTM P/E
Price-to-Earnings
750.6x
FY26e P/E
Forward estimate
13.8x
FY27e P/E
Forward estimate
11.9x
Current P/B
Price-to-Book
1.67x
Current P/TBV
Tangible Book Value
2.12x
Current EV/EBITDA
Enterprise Value
19.3x
FY26e EV/EBITDA
Forward estimate
N/A
FY27e EV/EBITDA
Forward estimate
N/A

Dividend

CSN pays a dividend yield of 6.80%.

Current Yield
6.80%
FY27e Net Div Yield
7.48%
FY26e Gross DPS
0.234
FY27e Gross DPS
0.241

Dividend Per Share Forecast

3. Profitability

Score: 89/280

How profitable is CSN relative to its peers?

0/7
profitability criteria met
✗
TTM Profit Margin0.2%
Range: 15 - 30Rank 250/280
–
T12 FCF MarginN/A
Range: N/A
–
FY27e RoEN/A
Range: 10 - 16
✗
FY26 EPS Growth554.9%
Range: 8 - 15Rank 3/280
✗
FY27e EPS Growth629.0%
Range: 6 - 12Rank 3/280
–
NIMN/A
Range: 1.5 - 3.2
–
Expense RatioN/A
Range: 50 - 65
TTM Profit Margin
0.2%
Current RoCE
-2.8%
FY27e RoE
N/A
T12 FCF Margin
N/A

EPS Growth

4. Solvency

Score: 232/280

How strong is CSN's balance sheet and financial position?

0/6
solvency criteria met
✗
Debt/Eqt0.36x
Range: 0.5x - 1.5xRank 118/280
–
Interest Coverage RatioRank 234
Range: N/ARank 234/280
–
Net Leverage RatioN/A
Range: N/A
–
Altman Z-Score (Manufacturing)N/A
Range: N/ARank 240/280
–
Z-Score (Non Manufacturing)Rank 246
Range: N/ARank 246/280
–
CapAdeq Ratio Tier1N/A
Range: 13 - 18

Key Solvency Metrics

Debt/Eqt
0.36x
Net Leverage Ratio
N/A
Interest Coverage
Rank 234
T12 FCF Margin
N/A

Altman Z-Score

N/A
Distress Zone
01.812.995+

5. Asset Efficiency

Score: 227/280

How efficiently does CSN deploy its assets and intellectual capital?

0/5
asset efficiency criteria met
–
Efficiency RatioN/A
Range: 50 - 70
–
TTM Asset Turnover Ratio0.03x
Range: N/ARank 262/280
–
TTM CAPEX/SalesN/A
Range: 1 - 3
–
Working Capital TurnoverN/A
Range: N/A
–
R&D/Sales FY27eN/A
Range: N/A

Overall Asset Efficiency Rank

Rank within sector peers#227/280
Best (1)Worst (280)

6. Market Trading

Score: 125/280

How liquid and actively traded is CSN?

1/2
market trading criteria met
✗
Intraday Sentiment (%)87.0%
Range: 40 - 75Rank 30/280
–
10D-Avg v/s 3M-Avg Vol89%
Range: N/ARank 50/280
✓
Avg Directional Index 30D27.4
Range: 012 - 45Rank 58/280
–
Parabolic SAR341.37
Range: N/ARank 186/280
–
Stock Rating RankRank 100
Range: N/ARank 100/280
Market Cap
£746,445,743
Enterprise Value
£539,945,743

Trading Volume

7. Technical

Score: 112/280

What do the technical indicators say about CSN?

0/5
technical criteria met
–
CMP v/s 52-WH-14.8%
£3.78£2.65
-14.8%CMP: £3.22
Range: N/ARank 170/280
–
CMP v/s 52-WL21.5%
£3.78£2.65
+21.5%CMP: £3.22
Range: N/ARank 119/280
–
RSI 14D10.6
010.6 - Oversold100
Range: N/ARank 100/280
–
MA50 - MA200Bullish
£3.23+0.23£3.46
Range: N/ARank 120/280
–
MACD Rank-3.66
Golden Cross
MACD: -3.66
Range: N/A

RSI (14 Day)

10.6
Oversold
0 (Oversold)50100 (Overbought)

Moving Averages

50 SMA£3.46
200 SMA£3.23
SignalGolden Cross (Bullish)
MACD-3.66

Risk Metrics

Beta
N/A
3-Yr Std Dev
N/A
5-Yr Std Dev
N/A

Peer Comparison

How does CSN compare to other Financials stocks?

Overall Rank Comparison

Factor Score Comparison

StockRankLiquidityValuationProfitabilitySolvencyMkt TradingTechnical
CSN#883516889232125112
MUT.L#3128382456278
RTW.L#51167914569229
BPCR.L#71633456911276
RCP.L#9179262259132
AGT.L#111085755729079
TBCG.L#1429553825712918
Sponsored
Healthcare Discovery Monitor
Live
Healthcare Discovery Monitor
Healthcare Discovery Monitorby StrategyLand

Catch Healthcare Events Before the Market Moves

SEC filings, FDA approvals, clinical trials, and regulatory events - scored for significance across 4 global markets.

10+
Sources
4
Markets
12h
Cycle
50+
Keywords
USUKCNEU
Launch Monitor

Methodology Note

The analysis presented for Chesnara PLC is produced using Strategyland's proprietary 7-factor quantitative model, which evaluates each stock across Liquidity, Valuation, Profitability, Solvency, Asset Efficiency, Market Trading, and Technical dimensions. Individual factor scores and the composite rank reflect relative rankings within the FTSE 100 universe — a lower rank number indicates stronger performance in that category.

Underlying financial and market data is sourced from LSEG (London Stock Exchange Group) and processed through our scoring engine. Scores are recalculated as new data becomes available and should be interpreted as a systematic screening output, not a forecast of future share price performance.

This content is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance and factor rankings are not indicative of future results. Please read our Risk Disclaimer before making any investment decisions.

Note: The information provided is not intended as an offer or solicitation for the purchase or sale of any financial instruments but for investor relations purposes only. The aforementioned securities were offered to the public and currently trade on the secondary market at the exchange mentioned above. It is recommended that investors considering investing in any of these notes consult an approved MiFID Financial Advisor prior to investing.